We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Proposed FDA Rule Gives More Flexibility for Biologics Testing
Proposed FDA Rule Gives More Flexibility for Biologics Testing
June 24, 2011
The FDA is proposing amendments to its sterility testing requirements for biologics to give industry greater flexibility and encourage use of technologically up-to-date testing methods.